GENERALIZED MYASTHENIA GRAVIS
Clinical trials for GENERALIZED MYASTHENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new GENERALIZED MYASTHENIA GRAVIS trials appear
Sign up with your email to follow new studies for GENERALIZED MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CAR-T therapy targets autoimmune muscle weakness
Disease control Not yet recruitingThis early study tests a new treatment called HN2301 in 6 adults with generalized myasthenia gravis, a condition causing muscle weakness. The main goal is to check safety and side effects. Researchers will also measure how the therapy affects immune cells in the blood.
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE1 • Sponsor: Shenzhen MagicRNA Biotechnology Co., Ltd • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
New study lets MG patients rate their own symptoms on rystiggo
Knowledge-focused Not yet recruitingThis study watches 50 adults with generalized myasthenia gravis (gMG) who are taking the drug Rystiggo (rozanolixizumab). It does not test the drug itself, but instead uses a new patient questionnaire to track how symptoms like fatigue and muscle weakness change over 9 months. Th…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated May 17, 2026 05:07 UTC